E-DRUG: Need more standardised guidance on quality control of substandard & falsified medicines
-----------------------------------------------------------------------------------------------------------------------
Spurious, falsely-labelled, falsified and/or counterfeit products infiltrating
the pharmaceutical supply chains continue to pose a global public health
risk. Strategic quality control testing is a cornerstone of the fight
against these products. A survey among QC laboratories in all six WHO
regions has provided more insight on how this testing is conducted in
Member States.
WHO Drug Information article:
http://www.who.int/medicines/publications/druginformation/WHO_DI_28-3_MedicinesQuality.pdf?ua=1